You are here

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Systematic review and meta-analysis
Benefits of blood pressure lowering are seen across levels of baseline blood pressure, comorbidity and drug class

https://doi.org/10.1136/ebmed-2016-110446

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests During the past 20 years, MRN has participated in trials that have received funding from SmithKline Beecham, AstraZeneca, Bayer, Sanofi-Aventis, Merck Sharpe and Dohme, Pfizer, Servier Laboratories and Bristol-Myers Squibb. MRN has served on advisory boards for Sanofi-Aventis, Novartis, Schering-Plough, Solvay Pharmaceuticals and AMGEN. MRN has prepared educational material for Servier Laboratories, AstraZeneca Bristol-Myers Squibb and MediMark. MRN has received conference and travel support from Bayer HealthCare AG, Merck Sharpe and Dohme, Novartis and Sanofi-Aventis.

    • Provenance and peer review Commissioned; internally peer reviewed.